Metformin diabetes drugs recall in Canada: NDMA impurity
In plain language
This recall involves certain brands of metformin diabetes drugs sold in Canada. They are being recalled because they contain or may contain a nitrosamine impurity (NDMA) above acceptable limits. Do not stop taking your medication without first speaking to your healthcare provider.
What to do
- Do not stop taking your medication without first discussing options with your healthcare provider.
- Talk to your healthcare provider to discuss treatment options if you are taking a recalled product.
- Refer to the official notice for detailed information on affected lots.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Cancer risk due to NDMA impurity
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Cancer risk due to NDMA impurity
What should consumers do?
Do not stop taking your medication without first discussing options with your healthcare provider. Talk to your healthcare provider to discuss treatment options if you are taking a recalled product. Refer to the official notice for detailed information on affected lots.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Cancer risk due to NDMA impurity
When was this product recalled?
This product was recalled on June 13, 2020.